Point72 Hong Kong’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-437
| Closed | -$35K | – | 2528 |
|
|
2021
Q1 | $35K | Sell |
437
-139
| -24% | -$10.9K | ﹤0.01% | 1358 |
|
|
2020
Q4 | $45K | Buy |
+576
| New | +$33.8K | ﹤0.01% | 1251 |
|
|
2020
Q2 | – | Sell |
-639
| Closed | -$23K | – | 1528 |
|
|
2020
Q1 | $23K | Sell |
639
-1,160
| -64% | -$66K | 0.01% | 521 |
|
|
2019
Q4 | $128K | Buy |
1,799
+539
| +43% | +$39.1K | 0.03% | 451 |
|
|
2019
Q3 | $94K | Buy |
+1,260
| New | +$107K | 0.03% | 469 |
|
|
2019
Q1 | – | Sell |
-64
| Closed | -$5K | – | 1377 |
|
|
2018
Q4 | $5K | Sell |
64
-1,679
| -96% | -$139K | ﹤0.01% | 644 |
|
|
2018
Q3 | $160K | Buy |
+1,743
| New | +$166K | 0.05% | 246 |
|
|
2018
Q2 | – | Sell |
-400
| Closed | -$45K | – | 1298 |
|
|
2018
Q1 | $45K | Buy |
+400
| New | +$44.8K | 0.02% | 476 |
|
|
2017
Q1 | – | Sell |
-192
| Closed | -$15K | – | 1097 |
|
|
2016
Q4 | $15K | Buy |
+192
| New | +$14.9K | 0.02% | 595 |
|
Point72 Hong Kong's CMD Position: Q2 2021 in Review
Point72 Hong Kong sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 437 shares — an estimated $35K sold.
Point72 Hong Kong first reported a position in CMD in Q4 2016 and held it in 9 quarters. The position peaked at $160K in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Point72 Hong Kong reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Point72 Hong Kong sold 437 Cantel Medical Corporation shares in Q2 2021, an estimated $35K.
- Point72 Hong Kong first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 9 quarters.
- Point72 Hong Kong's Cantel Medical Corporation position peaked at $160K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.